Biodesix (BDSX) Shares Outstanding (Diluted Average) (2021 - 2026)
Biodesix filings provide 6 years of Shares Outstanding (Diluted Average) readings, the most recent being $9.7 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 32.27% to $9.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.7 million, a 32.27% increase, with the full-year FY2025 number at $7.6 million, up 16.71% from a year prior.
- Shares Outstanding (Diluted Average) hit $9.7 million in Q1 2026 for Biodesix, up from $7.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $146.7 million in Q2 2025 to a low of $6.5 million in Q4 2024.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $40.4 million (2022), compared with a mean of $52.1 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 1457.04% in 2022 and later crashed 92.49% in 2025.
- Biodesix's Shares Outstanding (Diluted Average) stood at $42.1 million in 2022, then skyrocketed by 95.03% to $82.1 million in 2023, then tumbled by 92.12% to $6.5 million in 2024, then rose by 16.71% to $7.6 million in 2025, then increased by 27.88% to $9.7 million in 2026.
- The last three reported values for Shares Outstanding (Diluted Average) were $9.7 million (Q1 2026), $7.6 million (Q4 2025), and $7.5 million (Q3 2025) per Business Quant data.